Platinum-Resistant Lung Small Cell Carcinoma

specific

Lung small cell carcinoma that is resistant to platinum therapy.

11

Centers

13

Active Trials

Cancer Funding

Top Centers for Platinum-Resistant Lung Small Cell Carcinoma(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.0
2
NCI Comprehensive
High-Volume Research Center
73.0
3
NCI Comprehensive
Active Research Program
50.5
4
NCI Comprehensive
Active Research Program
50.5
5
NCI Comprehensive
Active Research Program
50.5
6
NCI Comprehensive
Active Research Program
50.5
7
NCI Comprehensive
Active Research Program
50.5
8
NCI Comprehensive
Active Research Program
50.5
9
Active Research Program
50.5
10
NCI Comprehensive
Active Research Program
50.5
11
Active Research Program
50.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →